Alzheimer’s drug prescribed ‘off-label’ for mild cognitive impairment could pose risk for some

UCLA RESEARCH ALERT

Related Content

Articles:

Media Contact

Laura Perry
310-794-4022
lperry@sonnet.ucla.edu
Share: